nattokinase and Colonic-Neoplasms

nattokinase has been researched along with Colonic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for nattokinase and Colonic-Neoplasms

ArticleYear
A nano polymer conjugate for dual drugs sequential release and combined treatment of colon cancer and thrombotic complications.
    Materials science & engineering. C, Materials for biological applications, 2020, Volume: 110

    Thrombotic complications turn into the second leading cause of death in colon cancer patients due to the hypercoagulable state caused by malignancy. Therefore, it is necessary to treat colon cancer and its thrombosis complications simultaneously. Herein, a nano polymer conjugate based on disulfide cross-linked low-generation peptide dendrimers was developed to treat colon cancer and its thrombotic complications. First, two-generation polyglutamic acid dendrimer was bonded to nattokinase (NK) and then cross-linkers containing disulfide linkages were used to obtain polymer conjugates (NK-G

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Combined Modality Therapy; Dendrimers; Doxorubicin; Drug Carriers; Drug Liberation; Endocytosis; Fibrinolytic Agents; HCT116 Cells; Humans; Mice; Nanoparticles; Polyglutamic Acid; Polymers; RAW 264.7 Cells; Subtilisins; Thrombosis

2020